Search - tctmd.com

Displaying 141 - 160 of 189

Sort: Relevancy | Date

News Features

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

Michael O'Riordan

January 11, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Opinion CV Team Dispatch

December 2020 News Roundup

L.A. McKeown

December 01, 2020

News Features

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

Todd Neale

November 02, 2020

News Daily News

Influenza and Acute CV Events Can Go Hand in Hand

Caitlin E. Cox

August 25, 2020

News Daily News

‘Striking Similarities’ for COVID-19 Inflammatory Syndromes in Children, Adults

Todd Neale

August 17, 2020

News Daily News

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Michael O'Riordan

August 14, 2020

News Daily News

Premature CV Death Is Not Declining Fast Enough: National Data

L.A. McKeown

July 31, 2020

News Conference News SCCT 2020

For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change

Yael L. Maxwell

July 28, 2020

News Daily News

COVID-19’s Kawasaki-Like MIS-C Diagnosis Is Cropping Up in Adults

Shelley Wood

July 22, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

Myocardial Injury Seen in Over One-Third of Hospitalized COVID-19 Patients

Michael O'Riordan

June 10, 2020

News Daily News

High-Intensity Sport Post-COVID: Expert Advice From Sports Cardiologists

Caitlin E. Cox

May 13, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

Carpal Tunnel Linked to Higher Rates of Amyloidosis and Heart Failure

L.A. McKeown

July 02, 2019

News Conference News HRS 2019

Cancer Survivors With Heart Failure Respond Well to CRT

Todd Neale

May 14, 2019

News Daily News

In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients

L.A. McKeown

May 07, 2019

News Daily News

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Michael O'Riordan

May 06, 2019

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

Advertisement

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

December 2020 News Roundup

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

Influenza and Acute CV Events Can Go Hand in Hand

‘Striking Similarities’ for COVID-19 Inflammatory Syndromes in Children, Adults

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Premature CV Death Is Not Declining Fast Enough: National Data

For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change

COVID-19’s Kawasaki-Like MIS-C Diagnosis Is Cropping Up in Adults

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Myocardial Injury Seen in Over One-Third of Hospitalized COVID-19 Patients

High-Intensity Sport Post-COVID: Expert Advice From Sports Cardiologists

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Carpal Tunnel Linked to Higher Rates of Amyloidosis and Heart Failure

Cancer Survivors With Heart Failure Respond Well to CRT

In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content